关注
Vandana Patravale
Vandana Patravale
Professor of pharmaceutics, ICT
在 ictmumbai.edu.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Nanosuspensions: a promising drug delivery strategy
VB Patravale, AA Date, RM Kulkarni
Journal of pharmacy and pharmacology 56 (7), 827-840, 2004
11542004
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
S Mukherjee, A Date, V Patravale, HC Korting, A Roeder, G Weindl
Clinical interventions in aging 1 (4), 327-348, 2006
6552006
Polymeric nanoparticles for targeted treatment in oncology: current insights
RH Prabhu, VB Patravale, MD Joshi
International journal of nanomedicine, 1001-1018, 2015
5222015
Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery
KA Shah, AA Date, MD Joshi, VB Patravale
International journal of pharmaceutics 345 (1-2), 163-171, 2007
4482007
Nanostructured lipid carrier (NLC) based gel of celecoxib
M Joshi, V Patravale
International journal of pharmaceutics 346 (1-2), 124-132, 2008
3922008
Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles
AA Date, MD Joshi, VB Patravale
Advanced drug delivery reviews 59 (6), 505-521, 2007
3882007
Novel cosmetic delivery systems: an application update
VB Patravale, SD Mandawgade
International journal of cosmetic science 30 (1), 19-33, 2008
3722008
Formulation and evaluation of nanostructured lipid carrier (NLC)–based gel of Valdecoxib
M Joshi, V Patravale
Drug development and industrial pharmacy 32 (8), 911-918, 2006
2682006
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review
S Mhatre, T Srivastava, S Naik, V Patravale
Phytomedicine 85, 153286, 2021
2642021
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation
YG Bachhav, VB Patravale
International Journal of Pharmaceutics 365 (1-2), 175-179, 2009
2552009
Current strategies for engineering drug nanoparticles
AA Date, VB Patravale
Current opinion in colloid & interface science 9 (3-4), 222-235, 2004
2492004
Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations
PP Desai, AA Date, VB Patravale
Drug Discovery Today: Technologies 9 (2), e87-e95, 2012
2482012
Development of SLNs from natural lipids: application to topical delivery of tretinoin
SD Mandawgade, VB Patravale
International journal of pharmaceutics 363 (1-2), 132-138, 2008
2472008
Endosomal escape: a bottleneck in intracellular delivery
HK Shete, RH Prabhu, VB Patravale
Journal of nanoscience and nanotechnology 14 (1), 460-474, 2014
2142014
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
VP Chavda, LK Vora, AK Pandya, VB Patravale
Drug discovery today 26 (11), 2619-2636, 2021
1892021
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject
M Joshi, S Pathak, S Sharma, V Patravale
International journal of pharmaceutics 364 (1), 119-126, 2008
1862008
The upcoming field of theranostic nanomedicine: an overview
P Prabhu, V Patravale
Journal of Biomedical Nanotechnology 8 (6), 859-882, 2012
1702012
Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine
AA Kale, VB Patravale
AAPS pharmscitech 9, 191-196, 2008
1692008
Microneedles for transdermal drug delivery: a systematic review
S Dharadhar, A Majumdar, S Dhoble, V Patravale
Drug development and industrial pharmacy 45 (2), 188-201, 2019
1582019
Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization
H Shete, V Patravale
International journal of pharmaceutics 454 (1), 573-583, 2013
1572013
系统目前无法执行此操作,请稍后再试。
文章 1–20